Cargando…

Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation

The mechanisms of persistent central nervous system (CNS) inflammation in people with HIV (PWH) despite effective antiretroviral therapy (ART) are not fully understood. We have recently shown that plasma anti-CD4 IgGs contribute to poor CD4(+) T cell recovery during suppressive ART via antibody-medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Da, Luo, Zhenwu, Fu, Xiaoyu, Stephenson, Sophie, Di Germanio, Clara, Norris, Philip J., Fuchs, Dietmar, Ndhlovu, Lishomwa C., Li, Quan-zhen, Zetterberg, Henrik, Gisslen, Magnus, Price, Richard W., Peng, Shifang, Jiang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729763/ https://www.ncbi.nlm.nih.gov/pubmed/34985329 http://dx.doi.org/10.1128/spectrum.01975-21

Ejemplares similares

Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1
por: Peluso, Michael J, et al.
Publicado: (2020)

Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression
por: Gisslen, Magnus, et al.
Publicado: (2021)

Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy
por: Gisslén, Magnus, et al.
Publicado: (2012)

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
por: Yilmaz, Aylin, et al.
Publicado: (2019)

Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection
por: Peterson, Julia, et al.
Publicado: (2014)

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
por: Hermansson, Linn, et al.
Publicado: (2019)

Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection
por: Price, Richard W., et al.
Publicado: (2013)

Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
por: Yilmaz, Aylin, et al.
Publicado: (2013)

Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance
por: Hagberg, Lars, et al.
Publicado: (2020)

Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study
por: Jespersen, Sofie, et al.
Publicado: (2016)

The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease
por: Mäkitalo, Signar, et al.
Publicado: (2015)

Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes
por: Abdulle, Sahra, et al.
Publicado: (2008)

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
por: Gisslén, Magnus, et al.
Publicado: (2009)

Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia – case report
por: Andersson, Lars-Magnus, et al.
Publicado: (2006)

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
por: Hagberg, Lars, et al.
Publicado: (2010)

Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients
por: Ferretti, Francesca, et al.
Publicado: (2016)

Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection
por: Ahlgren, Erika, et al.
Publicado: (2016)

Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection
por: Yilmaz, Aylin, et al.
Publicado: (2009)

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection
por: Anesten, Birgitta, et al.
Publicado: (2021)

Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection
por: Anesten, Birgitta, et al.
Publicado: (2022)

Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study
por: Yilmaz, Aylin, et al.
Publicado: (2006)

The cerebrospinal fluid proteome in HIV infection: change associated with disease severity
por: Angel, Thomas E, et al.
Publicado: (2012)

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection
por: Gisslén, Magnus, et al.
Publicado: (2005)

CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection
por: Gisslén, Magnus, et al.
Publicado: (2018)

Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients
por: Jessen Krut, Jan, et al.
Publicado: (2014)

Blood–brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV
por: Anesten, Birgitta, et al.
Publicado: (2016)

Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial
por: Thela, Lindokuhle, et al.
Publicado: (2023)

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
por: Gisslén, Magnus, et al.
Publicado: (2015)

Corrigendum to: “Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study” [EBioMedicine 3 (216) 135–140]
por: Gisslén, Magnus, et al.
Publicado: (2016)

Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms
por: Edén, Arvid, et al.
Publicado: (2022)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study
por: Alagaratnam, Jasmini, et al.
Publicado: (2021)

Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis
por: Edén, Arvid, et al.
Publicado: (2021)

Blood biomarkers for HIV infection with focus on neurologic complications—A review
por: Hagberg, Lars, et al.
Publicado: (2022)

Cohort profile: a longitudinal study of HIV infection in the central nervous system with focus on cerebrospinal fluid – the Gothenburg HIV CSF Study Cohort
por: Hagberg, Lars, et al.
Publicado: (2023)

Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation
por: Liu, Yanlong, et al.
Publicado: (2020)

Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patients
por: Lim, Bryant, et al.
Publicado: (2019)

The origin and nature of the complex autoantibody profile in cerebrospinal fluid
por: Kheirkhah, Rahil, et al.
Publicado: (2019)

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment
por: Edén, Arvid, et al.
Publicado: (2016)

Cerebrospinal Fluid Analysis Should Be Considered in Patients with Cognitive Problems
por: Zetterberg, Henrik, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2oltsak16t1igafabce0f6nce9